Trianz Releases Acceliant 6.1 after Successful R&D Partnership with Registrat-MAPI

Share Article

Registrat-MAPI and Trianz Solutions are pleased to announce a further strengthening of their relationship via the release of Acceliant V6.1. Registrat-MAPI has utilized Acceliant since 2007 for many of their Late Phase clinical studies.

Collaborative Relationship: Registrat MAPI - Trianz Solutions

Our collaborative relationship with Trianz allows us to offer our clients innovative technologies and cutting-edge EDC specifically customized for late phase studies.

REGISTRAT-MAPI and Trianz Solutions are pleased to announce a further strengthening of their relationship via the release of Acceliant V6.1. REGISTRAT-MAPI has utilized Acceliant since 2007 for many of their Late Phase clinical studies. Acceliant V6.1, released earlier this year incorporates a number of groundbreaking functional enhancements and a new UI architecture, identified by REGISTRAT-MAPI, based on their unique experiences as the industry’s largest leading global clinical research organization (CRO) dedicated solely to ‘real life’ late phase clinical research, and Acceliant users.

Stephen Webb, REGISTRAT-MAPI, President North America stated that the collaborative relationship with Trianz, “allows us to offer our clients innovative technologies and cutting-edge EDC specifically customized for late phase studies. With Trianz and their dedicated team of EDC development professionals, our biometrics team’s eCRF development expertise, and by listening to our clients’ needs, REGISTRAT-MAPI can deliver ‘world class’ Late Phase research services and solutions.”

Acceliant 6.1 is a comprehensive, full life cycle e-Clinical Trials EDC platform comprised of Clinical Data Management, regulatory compliant Document Management, core Trial Management facilitating collaboration and site management, and rich business intelligence capabilities. What makes Acceliant unique is a proprietary Accelerated Trial Builder, which allows non-technical users to accomplish end-to-end configuration and build of a trial without the need for any programming. The Accelerated Trial Builder enables users to define data-fields, edit checks, code lists, complete CRF layouts, validate the build and then deploy the trial with a single click.

Based on an integrated design and architecture, all Acceliant modules and features have been designed and built as a single native platform. Version 6.1 includes technology-driven usability features that are beneficial when working with large trials involving thousands of sites and patients; several design improvements for efficiently handling large scale data sets; powerful capabilities for import/export of large data sets; and rapid edit and validation of test data. These enhancements provide benefits for all trial phases.

Commenting on the relationship, Sri Manchala, President and CEO of Trianz, adds, “Trianz continues our commitment as a client-oriented organization and our partnership with REGISTRAT-MAPI is a culmination of over 10 years of dedication to the clinical trials solution industry. Acceliant is an industry leading tool enabling biopharmaceutical companies to decrease time to market, integrate data and processes, and address regulatory requirements.” Mr. Manchala further added, “The ultimate goal of the Trianz technology and approach is to deliver speed and productivity in EDC for CROs, BioPharmaceutical and Medical Device companies worldwide. As such, Acceliant will positively impact their clinical trial management operations to make them more business intelligent, efficient and cost effective in a rapidly changing healthcare industry”.

REGISTRAT-MAPI and Trianz Solutions are collaborating in an R&D model for the benefit of the industry at large and will continue to share successful developments in future.

About REGISTRAT-MAPI
REGISTRAT-MAPI, the industry’s largest leading global clinical research organization (CRO) dedicated solely to ‘real life’ late phase clinical research, has extensive experience in the design, implementation and management of peri- and post-approval studies for biopharmaceutical and medical device clients. Our recent experience includes successful studies that reach into more than 32 countries. REGISTRAT-MAPI provides integrated clinical development services worldwide with offices in: Philadelphia, PA; Lexington, KY; Paris and Lyon, France; Rome, Italy; London, England; Utrecht, Netherlands; and Frankfurt, Germany. Visit http://www.registratmapi.com.

About Trianz Solutions
For over a decade, Trianz Solutions (http://solutions.trianz.com) has been providing Fortune 1000 clients with innovative software platforms and associated professional services to be competitive in meeting the challenges of today’s dynamic market conditions. The Acceliant eClinical Suite is its pre-eminent offering that continues its 10-year history of providing innovative solutions for the Life Sciences industry.

Trianz Solutions is a division of Trianz (http://www.trianz.com ), a client-oriented organization that provides an integrated set of Consulting, IT and BPO solutions, each enabled by innovative and proprietary global execution model. Trianz firmly believes that the flawless execution of business, technology and operational initiatives is a key ingredient of business success. And our mission is to partner with business leaders, who share the belief that Execution Matters. We understand top management vision and objectives, visualize business results and translate these to the execution of strategy using relevant technology and process outsourcing.

For additional information, please contact:
Prashant Bhavaraju,
Director, Marketing
Trianz
Email: sales(dot)acceliant(at)trianz(dot)com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Prashant Bhavaraju
Visit website